4

PRIMARY DOCUMENT

Company: Dianthus Therapeutics, Inc. /DE/
Filed: September 19, 2019
Period of Report: September 19, 2019
Accession Number: 0001562180-19-004884

View Document ↗ View on SEC.gov ↗